Seeking Alpha
31 Oct 2026, 13:25 UTC · 3h ago
Hess Midstream: The Quiet Before The Storm
Impact · against what's priced in
The outlook for HMPM is negative due to a projected 25% EBITDA contraction by 2027 despite asset growth. For CVX, the news suggests a potential strategic exit from the Bakken, which threatens the upstream volume growth assumptions currently supporting its valuation.
- CVX−0.40
Challenges what's priced in
- The price assumes
Upstream volume growth of 2%-3% annually through 2030
A potential long-term exit from the Bakken directly contradicts the assumption that upstream volume growth will remain steady enough to offset severe downstream revenue declines.
What CVX's price assumes · Aug 26
